Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
28
|
802
|
1.000 |
strong |
0.956 |
0 |
77
|
1992 |
2020 |
Hereditary Breast and Ovarian Cancer Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases
|
Neoplastic Process
|
17
|
2106
|
0.800 |
strong |
0.986 |
800 |
874
|
1990 |
2020 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
11
|
20
|
0.800 |
strong |
0.965 |
0 |
6
|
1992 |
2020 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
3
|
2273
|
0.700 |
definitive |
1.000 |
451 |
2254
|
1976 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
39
|
436
|
0.700 |
None |
0.965 |
1 |
67
|
1992 |
2020 |
FANCONI ANEMIA, COMPLEMENTATION GROUP S
|
disease |
|
Disease or Syndrome
|
1
|
28
|
0.700 |
definitive |
1.000 |
0 |
28
|
2013 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
15
|
37
|
0.700 |
None |
0.955 |
0 |
5
|
1992 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
34
|
314
|
0.500 |
None |
0.976 |
17 |
58
|
1976 |
2019 |
PANCREATIC CANCER, SUSCEPTIBILITY TO, 4
|
disease |
|
Finding
|
1
|
22
|
0.400 |
None |
1.000 |
0 |
22
|
2003 |
2018 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
5
|
150
|
0.200 |
None |
1.000 |
1 |
2
|
2001 |
2020 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
15
|
28
|
0.200 |
None |
1.000 |
0 |
1
|
1997 |
2020 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2
|
3
|
0.200 |
None |
0.966 |
0 |
2
|
1992 |
2020 |
Neoplastic Syndromes, Hereditary
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
67
|
6385
|
0.150 |
None |
1.000 |
744 |
705
|
1975 |
2019 |
Invasive Ductal Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2
|
4
|
0.150 |
None |
0.833 |
1 |
2
|
2000 |
2017 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
9
|
11
|
0.110 |
None |
1.000 |
0 |
1
|
2017 |
2017 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
disease |
|
Finding
|
2
|
2633
|
0.100 |
None |
|
0 |
1
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
1
|
|
|
PANCREATIC CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Ovarian Serous Surface Papillary Adenocarcinoma
|
disease |
|
Neoplastic Process
|
2
|
2
|
0.100 |
None |
|
0 |
1
|
|
|
Lymphoma, Non-Hodgkin, Familial
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
15
|
33
|
0.100 |
None |
|
0 |
1
|
|
|
Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3
|
4
|
0.100 |
None |
|
0 |
1
|
|
|
increased risk of pancreatic cancer
|
phenotype |
Neoplasms
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
1
|
|
|